Table 2.
Assessment of Individual Risk Factors for SSI
| Variables | OR | 95% CI | P-value |
|---|---|---|---|
| Vedolizumab | 1.785 | [0.671, 4.747] | 0.246 |
| Age | 0.995 | [0.965, 1.027] | 0.776 |
| Sex, female | 1.141 | [0.425, 3.058] | 0.794 |
| Operative characteristics | |||
| Open (vs. laparoscopic) | 1.441 | [0.493, 4.216] | 0.505 |
| Ostomy (vs. anastomosis) | 0.881 | [0.321, 2.415] | 0.805 |
| Concomitant Immunomodulators | 0.765 | [0.184, 3.185] | 0.713 |
| Corticosteroid dependency* | 1.914 | [0.728, 5.029] | 0.188 |
| Malnutrition | 3.110 | [1.110, 8.713] | 0.031* |
*
≥100 days of corticosteroid use in 1 year